MDM2 and esophageal adenocarcinoma: Among the 1114 cases with an adenocarcinoma of the esophagus, gastroesophageal junction, or stomach documented in the cBioPortal database (search date 17 September 2023), 72 (6.5%) cases harbored an MDM2 amplification and only 8 (0.7%) a mutation.